Quantum (IFC-39084)

Regions
  • East Asia and Pacific
Geographic location where the impacts of the investment may be experienced.
Countries
  • Indonesia
Geographic location where the impacts of the investment may be experienced.
Financial Institutions
  • International Finance Corporation (IFC)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Approved
Stage of the project cycle. Stages vary by development bank and can include: pending, approval, implementation, and closed or completed.
Bank Risk Rating
B
Environmental and social categorization assessed by the development bank as a measure of the planned project’s environmental and social impacts. A higher risk rating may require more due diligence to limit or avoid harm to people and the environment. For example, "A" or "B" are risk categories where "A" represents the highest amount of risk. Results will include projects that specifically recorded a rating, all other projects are marked ‘U’ for "Undisclosed."
Voting Date
Apr 26, 2017
Date when project documentation and funding is reviewed by the Board for consideration and approval. Some development banks will state a "board date" or "decision date." When funding approval is obtained, the legal documents are accepted and signed, the implementation phase begins.
Borrower
IDS Medical Systems Group Limited
A public entity (government or state-owned) provided with funds or financial support to manage and/or implement a project.
Sectors
  • Education and Health
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
Equity
The categories of the bank investment: loan, grant, guarantee, technical assistance, advisory services, equity and fund.
Investment Amount (USD)
$ 60.00 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Project Cost (USD)
$ 130.00 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Primary Source

Original disclosure @ IFC website

Updated in EWS Oct 14, 2018

Disclosed by Bank Feb 21, 2017

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description
If provided by the financial institution, the Early Warning System Team writes a short summary describing the purported development objective of the project and project components. Review the complete project documentation for a detailed description.

According to IFC website, the project involves a potential equity investment of $60 million in IDS Medical Systems Group Limited, a leading integrated medical distribution and solutions provider in Asia. IDS provides medical equipment, parts, consumables and services to numerous healthcare institutions including private and public hospitals, day surgery centers, specialist and primary care clinics, laboratories and nursing homes. The company currently operates in various markets including Indonesia, Malaysia, Singapore, Thailand, Hong Kong, Taiwan, Vietnam and the Philippines. IDS is majority owned by the Fung group of companies, who have holdings in trading, logistics, distribution and retailing; individual shareholders own the remaining shares of the company.

Investment Description
Here you can find a list of individual development financial institutions that finance the project.

The IFC Investee Company is IDS Medical Systems Group Limited. The immediate Sponsor is IDS Medical Holdings Limited (the shareholder of the Company). The project will also have the financial backing of Fung Investments Limited, the Fung family investment vehicle for high growth and strategic investments. Fung Investments Limited has geographically and sectorally diversified investments. The Fung Group is globally renowned for its expertise in trading, logistics, distribution and retailing.


Contact Information
This section aims to support the local communities and local CSO to get to know which stakeholders are involved in a project with their roles and responsibilities. If available, there may be a complaint office for the respective bank which operates independently to receive and determine violations in policy and practice. Independent Accountability Mechanisms receive and respond to complaints. Most Independent Accountability Mechanisms offer two functions for addressing complaints: dispute resolution and compliance review.

Project Contact: Stewart Kwok
VP - Strategic Development, IDS Medical Systems (Hong Kong) Company Limited 
Office Address: 13/F Li & Fung Centre, 2 On Ping Street, Siu Lek Yuen, Shatin, Hong Kong
Website: https://www.idsmed.com/

ACCOUNTABILITY MECHANISM OF IFC

The Compliance Advisor Ombudsman (CAO) is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an IFC or MIGA- financed project. If you submit a complaint to the CAO, they may assist you in resolving a dispute with the company and/or investigate to assess whether the IFC is following its own policies and procedures for preventing harm to people or the environment. If you want to submit a complaint electronically, you can email the CAO at CAO@worldbankgroup.org. You can learn more about the CAO and how to file a complaint at http://www.cao-ombudsman.org/

How it works

How it works